17 articles for S Malhotra
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
When Does Chemical Elaboration Induce a Ligand To Change Its Binding Mode?

Fox Chase Cancer Center
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3.

Eli Lilly
Structure-Based Design and Evaluation of Reversible KRAS G13D Inhibitors.

Genentech
Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1).

Genentech
Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D

University of Pennsylvania
Discovery of novel, potent, isosteviol-based antithrombotic agents.

Peking University
The development of potent and selective bisarylmaleimide GSK3 inhibitors.

Lilly Research Laboratories
3-BETA-HSD1 INHIBITORS AND COMPOSITIONS AND USES THEREOF

The Cleveland Clinic Foundation
Compounds for the treatment of respiratory diseases

University of Melbourne
PYRROLO[1,2-b]-2-PYRIDAZINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

Suven Life Sciences
ISOXAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERED RELATED THERETO

Arena Pharmaceuticals
TYK2 INHIBITORS

Biogen Ma
ACLY inhibitors and uses thereof

Nimbus Artemis
Heterocycles useful as anti-cancer agents

Hangzhou Innogate Pharma
Inhibitors of lysine specific demethylase-1

Celgene Quanticel Research
Therapeutically active compounds and their methods of use

Agios Pharmaceuticals
Thermodynamic basis of resistance to HIV-1 protease inhibition: calorimetric analysis of the V82F/I84V active site resistant mutant.

The Johns Hopkins University